Avatar

Advances in Applied and Pharmaceutical Sciences Journal 

ISSN 2457-0842

DOI: 10.26768

Abstract


Volume 1 Issue 1, July-August 2017, Pages:18-23


Authors: Tushita Thakur, P Y Kulkarni
[Download PDF]
Abstract: Irritable bowel syndrome (IBS) is a functional GI disorder characterized by abdominal pain and altered bowel habits in the absence of specific and unique organic pathology. It is also the most common reason for referral to gastroenterologists3. Approximately 10% to 20% of the general adult population has reported symptoms compatible with IBS. Patients often experience the onset of symptoms as young adults and most patients have their first symptoms before the age of 35. IBS has both physiological and psychological determinants. Altered gastrointestinal motility, visceral hyperalgesia, disturbance of brain-gut interaction, genetic and environmental factors, and psychosocial disturbances are variably involved, depending upon the individual. About 50% of IBS patients referred to hospital meet criteria for a psychiatric diagnosis including anxiety, depression, somatisation and neurosis. Panic attacks are also common. IBS has a major impact on the quality of life as it affects social interactions and professional opportunities in suffering population. Thus, IBS has direct financial cost as well as indirect cost affecting quality of life. Currently there is no agreement on the best form of treatment for IBS. Homoeopathy is holistic, cost effectiveness and free of side effects. In the present study, Homoeopathic medicines were prescribed in 30/200/1M potency after detailed case taking, case analysis and repertorization. The results presented are after six months of follow up. Majority of the patients reported highly significant improvement in all symptomatic assessment parameters (highly significant P < 0.01; P < 0.001). In a five point Likert scale nearly half of the patients (n=15, 50%) reported moderate overall improvement
Cite this article: T Thakur, P Y Kulkarni“ Efficacy Of Homoeopathic Treatment In “Irritable Bowel Syndrome” In Its Various Presentations - A Case Study“ Advances in Applied and Pharmaceutical Sciences Journal 2017, 1 (1);18-23